Talaris Therapeutics, Inc. Profile Avatar - Palmy Investing

Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ tran…

Biotechnology
US, Louisville [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of TALS's Analysis
CIK: - CUSIP: 87410C104 LEI: - UEI: -
Secondary Listings
TALS has no secondary listings inside our databases.